These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25265976)

  • 21. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
    Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
    Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
    Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
    Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of controlled physical activity as a method of therapy in patients with heart failure after invasive treatment of angina pectoris].
    Irzmański R; Kapusta J; Kowalski J
    Pol Merkur Lekarski; 2014 Aug; 37(218):77-81. PubMed ID: 25252439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).
    Kjøller-Hansen L; Steffensen R; Grande P
    J Am Coll Cardiol; 2000 Mar; 35(4):881-8. PubMed ID: 10732883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.
    Gómez-Garre D; González-Rubio ML; Muñoz-Pacheco P; Caro-Vadillo A; Aragoncillo P; Fernández-Cruz A
    Eur J Heart Fail; 2010 Sep; 12(9):903-12. PubMed ID: 20601374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Aukrust P
    Am Heart J; 2012 Dec; 164(6):878-83. PubMed ID: 23194488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival in patients with refractory angina.
    Henry TD; Satran D; Hodges JS; Johnson RK; Poulose AK; Campbell AR; Garberich RF; Bart BA; Olson RE; Boisjolie CR; Harvey KL; Arndt TL; Traverse JH
    Eur Heart J; 2013 Sep; 34(34):2683-8. PubMed ID: 23671156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Askevold ET; Gullestad L; Nymo S; Kjekshus J; Yndestad A; Latini R; Cleland JG; McMurray JJ; Aukrust P; Ueland T
    PLoS One; 2015; 10(8):e0133970. PubMed ID: 26288364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
    Inglis SC; McMurray JJ; Böhm M; Schaufelberger M; van Veldhuisen DJ; Lindberg M; Dunselman P; Hjalmarson A; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
    Eur J Heart Fail; 2010 Jul; 12(7):698-705. PubMed ID: 20501489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
    Zacà V; Rastogi S; Imai M; Wang M; Sharov VG; Jiang A; Goldstein S; Sabbah HN
    J Am Coll Cardiol; 2007 Aug; 50(6):551-7. PubMed ID: 17678740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].
    Mareev VIu
    Kardiologiia; 2008; 48(1):74-5. PubMed ID: 18261000
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
    Ghio S; Scelsi L; Latini R; Masson S; Eleuteri E; Palvarini M; Vriz O; Pasotti M; Gorini M; Marchioli R; Maggioni A; Tavazzi L;
    Eur J Heart Fail; 2010 Dec; 12(12):1345-53. PubMed ID: 20952767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosuvastatin in older patients with systolic heart failure.
    Kjekshus J; Apetrei E; Barrios V; Böhm M; Cleland JG; Cornel JH; Dunselman P; Fonseca C; Goudev A; Grande P; Gullestad L; Hjalmarson A; Hradec J; Jánosi A; Kamenský G; Komajda M; Korewicki J; Kuusi T; Mach F; Mareev V; McMurray JJ; Ranjith N; Schaufelberger M; Vanhaecke J; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
    N Engl J Med; 2007 Nov; 357(22):2248-61. PubMed ID: 17984166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment and risk of cardiovascular events and mortality.
    O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
    Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
    Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
    Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH.
    Jolicœur EM; Dunning A; Castelvecchio S; Dabrowski R; Waclawiw MA; Petrie MC; Stewart R; Jhund PS; Desvigne-Nickens P; Panza JA; Bonow RO; Sun B; San TR; Al-Khalidi HR; Rouleau JL; Velazquez EJ; Cleland JGF
    J Am Coll Cardiol; 2015 Nov; 66(19):2092-2100. PubMed ID: 26541919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ; Vaduganathan M; Lupi L; Ambrosy AP; Mentz RJ; Konstam MA; Nodari S; Subacius HP; Fonarow GC; Bonow RO; Gheorghiade M;
    Am J Cardiol; 2013 Feb; 111(4):574-81. PubMed ID: 23206923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of left ventricular ejection fraction in angina patients with severe coronary artery disease not amenable to revascularization.
    Gupta S; Pressman GS; Morris DL; Figueredo VM
    Coron Artery Dis; 2010 Aug; 21(5):278-80. PubMed ID: 20531008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relations of the duration of pre-existing angina pectoris, collateral circulation and left ventricular function after isolated coronary occlusion with or without myocardial infarction].
    Juillière Y; Danchin N; Grentzinger A; Suty-Selton C; Perrin O; Guenoun P; Pernot C; Cherrier F
    Arch Mal Coeur Vaiss; 1990 Oct; 83(11):1679-84. PubMed ID: 2122845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.